Back to PE Pentwater Capital Management LP
BCYC
Showing 0 of 13 quarters
Position history for PEPentwater Capital Management LP's holdings in Bicycle Therapeutics plc
No. Pentwater Capital Management exited its BCYC (Bicycle Therapeutics) position in Q2 2022. Its Q1 2022 13F listed 14,000 shares worth $614,000. Pentwater Capital Management first reported BCYC in Q2 2019 and held it in 12 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.